Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 2,300 | $37.50 | $86,250.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 10 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,850 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 100 | $37.60 | $3,760.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 9 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,150 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 300 | $37.65 | $11,295.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 8 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,250 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $37.55 | $7,510.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 7 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,550 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 500 | $37.75 | $18,875.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 6 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,750 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $37.70 | $7,540.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 5 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,250 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 68 | $37.80 | $2,570.40 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 4 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,450 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $38.00 | $7,600.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,518 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 400 | $37.90 | $15,160.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,718 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 20:30 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 100 | $37.85 | $3,785.00 |
DisclosureSEC source: 0001209191-18-047057 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,118 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:15 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 1,790 | $35.05 | $62,739.50 |
DisclosureSEC source: 0001209191-18-045515 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,218 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:15 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 5,336 | $35.00 | $186,760.00 |
DisclosureSEC source: 0001209191-18-045515 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,008 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 02, 2018 Filed Aug 20, 2018 20:05 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
OtherOrdinary Shares | 187,787 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-022801 · doc4.xml · nonDerivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · WFD-GP II, LLC Disclosed balance after: 438,167 F1 · kind: On August 2, 2018, WFD-GP II LLC distributed to certain of its economic members 187,787 of the Issuer's shares. None of the shares were distributed to Mr. Doyle. F1 · ownership.nature: On August 2, 2018, WFD-GP II LLC distributed to certain of its economic members 187,787 of the Issuer's shares. None of the shares were distributed to Mr. Doyle. F2 · ownership.nature: Mr. Doyle is the Managing Director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 20:13 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 100 | $35.05 | $3,505.00 |
DisclosureSEC source: 0001209191-18-044941 · doc4.xml · nonDerivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,344 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 20:13 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $35.03 | $7,005.00 |
DisclosureSEC source: 0001209191-18-044941 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,444 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 20:13 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 941 | $35.00 | $32,935.00 |
DisclosureSEC source: 0001209191-18-044941 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,644 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:17 UTC |
Shah PriteshChief Commercial Officer
|
GrantRestricted Stock Unit · Derivative | 11,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044944 · doc4.xml · derivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,152 Underlying: Ordinary Shares · 11,152 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of July 31, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of July 31, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:17 UTC |
Shah PriteshChief Commercial Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 20,458 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044944 · doc4.xml · derivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,458 Underlying: Ordinary Shares · 20,458 shares Expires 2028-07-30 F1 · derivative.exercise_date: Options to buy 20,458 ordinary shares will vest and become exercisable in equal installments on each of July 31, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:15 UTC |
HILLEMAN JERYL LDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 37,101 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044943 · doc4.xml · derivative · entry 1 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,101 Underlying: Ordinary Shares · 37,101 shares Expires 2028-07-30 F1 · derivative.exercise_date: This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:39 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 1,100 | $37.05 | $40,755.00 |
DisclosureSEC source: 0001209191-18-044402 · doc4.xml · nonDerivative · entry 5 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,585 F5 · price: On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,100 shares in multiple trades at prices ranging from $37.00 to $37.10. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:39 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 6,095 | $36.60 | $223,077.00 |
DisclosureSEC source: 0001209191-18-044402 · doc4.xml · nonDerivative · entry 4 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,685 F4 · price: On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 6,095 shares in multiple trades at prices ranging from $36.00 to $36.95. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:39 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 34,385 | $35.20 | $1,210,352.00 |
DisclosureSEC source: 0001209191-18-044402 · doc4.xml · nonDerivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,780 F3 · price: On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 34,385 shares in multiple trades at prices ranging from $35.00 to $35.90. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:39 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 17,437 | $34.44 | $600,530.28 |
DisclosureSEC source: 0001209191-18-044402 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,165 F2 · price: On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 17,437 shares in multiple trades at prices ranging from $34.00 to $34.98. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:39 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 3,710 | $33.86 | $125,620.60 |
DisclosureSEC source: 0001209191-18-044402 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,602 F1 · price: On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 3,710 shares in multiple trades at prices ranging from $33.70 to $33.95. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 17:14 UTC |
Palti YoramDirector · Chief Technology Officer
|
SaleOrdinary Shares | 27,685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-043113 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,071,054 F3 · price: On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,685 shares in multiple trades at prices ranging from $35.00 to $35.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 17:14 UTC |
Palti YoramDirector · Chief Technology Officer
|
SaleOrdinary Shares | 2,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-043113 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,098,739 F1 · price: On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,315 shares in multiple trades at prices ranging from $36.00 to $36.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:54 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Exercise / conversionWarrants · Derivative | 2,330 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-18-043088 · doc4.xml · derivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,330 shares Expires 2018-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable at any time through July 21, 2018 Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:54 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Exercise / conversionOrdinary Shares | 2,330 | $3.59 | $8,364.70 |
DisclosureSEC source: 0001209191-18-043088 · doc4.xml · nonDerivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 16:12 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
GrantOrdinary Shares | 1,231 | $17.26 | $21,240.91 |
DisclosureSEC source: 0001209191-18-042140 · doc4.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,305 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 16:11 UTC |
Kirson Eilon D.Chief Science Officer
|
GrantOrdinary Shares | 1,231 | $17.26 | $21,240.91 |
DisclosureSEC source: 0001209191-18-042137 · doc4.xml · nonDerivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,063 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 20:10 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
GrantOrdinary Shares | 1,191 | $17.26 | $20,550.71 |
DisclosureSEC source: 0001209191-18-042134 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,312 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 20:14 UTC |
Shah PriteshChief Commercial Officer
|
GrantOrdinary Shares | 1,231 | $17.26 | $21,240.91 |
DisclosureSEC source: 0001209191-18-042142 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,231 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 20:09 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantOrdinary Shares | 795 | $17.26 | $13,717.73 |
DisclosureSEC source: 0001209191-18-042132 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,113 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:08 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 29,565 | $0.00 Strike: $7.48 | $0.00 |
DisclosureSEC source: 0001209191-18-041549 · doc4.xml · derivative · entry 5 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 29,565 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:08 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 27,825 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-18-041549 · doc4.xml · derivative · entry 4 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,825 shares Expires 2023-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:08 UTC |
Ambrogi Michael J.Chief Operating Officer
|
SaleOrdinary Shares | 57,390 | $31.48 | $1,806,637.20 |
DisclosureSEC source: 0001209191-18-041549 · doc4.xml · nonDerivative · entry 3 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,558 F2 · price: On July 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 57,390 shares in multiple trades at prices ranging from $31.00 to $31.95. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:08 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 29,565 | $7.48 | $221,146.20 |
DisclosureSEC source: 0001209191-18-041549 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:08 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 27,825 | $7.03 | $195,609.75 |
DisclosureSEC source: 0001209191-18-041549 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:05 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 70,364 | $32.09 | $2,257,699.30 |
DisclosureSEC source: 0001209191-18-040018 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,318 F1 · shares: On June 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 70,364 shares in multiple trades at prices ranging from $32.00 to $32.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:16 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 8,308 | $32.04 | $266,147.61 |
DisclosureSEC source: 0001209191-18-038937 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,682 F2 · price: On June 20, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 8,308 shares in multiple trades at prices ranging from $32.00 to $32.20. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:16 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 621 | $32.00 | $19,872.00 |
DisclosureSEC source: 0001209191-18-038937 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,990 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 20:14 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 22,289 | $32.00 | $713,248.00 |
DisclosureSEC source: 0001209191-18-038536 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,611 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 16:12 UTC |
Palti YoramDirector · Chief Technology Officer
|
SaleOrdinary Shares | 30,000 | $31.09 | $932,802.00 |
DisclosureSEC source: 0001209191-18-038534 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,101,054 F1 · price: On June 15, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $30.875 to $31.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 16:23 UTC |
Palti YoramDirector · Chief Technology Officer
|
SaleOrdinary Shares | 30,000 | $31.64 | $949,269.00 |
DisclosureSEC source: 0001209191-18-038048 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,131,054 F1 · price: On June 14, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $31.40 to $31.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 20:22 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 200 | $32.00 | $6,400.00 |
DisclosureSEC source: 0001209191-18-038045 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,900 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:24 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 37,500 | $0.00 Strike: $11.46 | $0.00 |
DisclosureSEC source: 0001209191-18-038050 · doc4.xml · derivative · entry 4 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options exercised were fully vested as of the date hereof. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:24 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 30,750 | $0.00 Strike: $14.37 | $0.00 |
DisclosureSEC source: 0001209191-18-038050 · doc4.xml · derivative · entry 3 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,335 Underlying: Ordinary Shares · 30,750 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options exercised were fully vested as of the date hereof. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:24 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 37,500 | $11.46 | $429,750.00 |
DisclosureSEC source: 0001209191-18-038050 · doc4.xml · nonDerivative · entry 2 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:24 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 30,750 | $14.37 | $441,877.50 |
DisclosureSEC source: 0001209191-18-038050 · doc4.xml · nonDerivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 20:22 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 11,720 | $32.00 | $375,040.00 |
DisclosureSEC source: 0001209191-18-038045 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,100 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.